Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (131-140 of 228) with videos related to

Pageof 23
Sort By:
Cancers|May 4, 2026
Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast CancerAlice Decaminada, Raute Sunder-Plassmann, Weang-Kee Ho, et al.
Investigative Radiology|February 26, 2014
Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imagingKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Neuro-Oncology|January 19, 2017
Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM scoreAnna S Berghoff, Fabian Wolpert, Tim Holland-Letz, et al.
European Journal of Clinical Investigation|June 4, 2021
Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centreChristoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, et al.
Cancers|February 25, 2023
Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast CancerEva Welsch, Eva Schuster, Michael Krainer, et al.
Anti-Cancer Drugs|November 5, 2003
Capecitabine monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinomaCatharina Wenzel, Gottfried J Locker, Rupert Bartsch, et al.
NMR in Biomedicine|August 25, 2016
Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracyClaudio Spick, Hubert Bickel, Katja Pinker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2006
Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysisRupert Bartsch, Sabine Fromm, Margaretha Rudas, et al.
Breast Cancer Research and Treatment|July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancerRupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Cancer Treatment Reviews|November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancerRupert Bartsch, David Cameron, Eva Ciruelos, et al.
Pageof 23

Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Cancers|May 4, 2026
Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast CancerAlice Decaminada, Raute Sunder-Plassmann, Weang-Kee Ho, et al.
Investigative Radiology|February 26, 2014
Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imagingKatja Pinker, Wolfgang Bogner, Pascal Baltzer, et al.
Neuro-Oncology|January 19, 2017
Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM scoreAnna S Berghoff, Fabian Wolpert, Tim Holland-Letz, et al.
European Journal of Clinical Investigation|June 4, 2021
Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centreChristoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, et al.
Cancers|February 25, 2023
Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast CancerEva Welsch, Eva Schuster, Michael Krainer, et al.
Anti-Cancer Drugs|November 5, 2003
Capecitabine monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinomaCatharina Wenzel, Gottfried J Locker, Rupert Bartsch, et al.
NMR in Biomedicine|August 25, 2016
Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracyClaudio Spick, Hubert Bickel, Katja Pinker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2006
Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysisRupert Bartsch, Sabine Fromm, Margaretha Rudas, et al.
Breast Cancer Research and Treatment|July 29, 2008
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancerRupert Bartsch, Brigitte Mlineritsch, Michael Gnant, et al.
Cancer Treatment Reviews|November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancerRupert Bartsch, David Cameron, Eva Ciruelos, et al.
Pageof 23